4-MeTMP: Chemical Profile, Research Uses, Effects and Safety Information

4-MeTMP, also known as threo-4-Methylmethylphenidate or 4-Me-TMP, is a synthetic stimulant and a structural analogue of methylphenidate. Researchers have studied this compound because its molecular structure is closely related to other phenidate compounds. However, unlike approved medicines, 4-MeTMP does not have an established therapeutic role, and available evidence about its effects and long-term safety remains limited.

What Is 4-MeTMP?

4-MeTMP is a phenidate-related compound that contains a methyl substitution on the aromatic ring of the methylphenidate structure. Its scientific name is threo-4-methylmethylphenidate. The compound is also identified by names such as 4-MMPH and 4-Me-TMP. PubChem lists its molecular formula as C15H21NO2 and its molecular weight as approximately 247.33 g/mol.

Because its structure resembles methylphenidate, scientists have investigated its interaction with neurotransmitter systems. Nevertheless, structural similarity does not mean that the two compounds have the same potency, safety profile, or medical applications.

4-MeTMP Chemical Details

• Chemical name: threo-4-Methylmethylphenidate
• Common abbreviation: 4-MeTMP
• Alternative names: 4-Me-TMP, 4-MMPH
• Molecular formula: C15H21NO2
• Molecular weight: 247.33 g/mol
• Chemical class: Phenidate-related synthetic stimulant
• CAS number: 467468-40-2
• PubChem CID: 23815457

How Does 4-MeTMP Relate to Methylphenidate?

Methylphenidate is a well-known prescription stimulant used medically for conditions such as ADHD and narcolepsy. In contrast, 4-MeTMP is primarily discussed in scientific, forensic, and research contexts.

Studies indicate that 4-MeTMP interacts with dopamine-related transport mechanisms. However, available research suggests that it has different pharmacological characteristics from methylphenidate. In particular, published information describes it as somewhat less potent than methylphenidate in certain experimental models.

Therefore, researchers should not assume that results obtained with methylphenidate automatically apply to 4-MeTMP.

Research Interest in 4-MeTMP

Researchers have investigated 4MeTMP because changes to the phenidate structure can influence pharmacological activity. These investigations can help scientists understand how chemical structure affects interactions with neurotransmitter transporters.

Furthermore, recent research has examined the predicted absorption, distribution, metabolism, and excretion (ADME) characteristics of 4-MeTMP. A 2026 study used computational methods to examine potential gastrointestinal absorption, brain penetration, metabolism, and elimination pathways. The authors also emphasized that several predictions require further experimental validation.

Why Is ADME Research Important?

ADME research helps scientists understand what may happen to a compound after it enters the body. For 4MeTMP, computational models suggest potential gastrointestinal absorption and brain penetration. However, these findings are predictions rather than proof of clinical safety or effectiveness.

Potential Effects and Safety Concerns

Because 4MeTMP is a stimulant-related compound, researchers have considered adverse effects associated with its pharmacological activity. Available toxicological literature indicates that phenidate-like compounds may be associated with effects such as increased heart rate, elevated blood pressure, anxiety, irritability, and paranoia.

However, the available human evidence for 4-MeTMP remains limited. Consequently, its complete short-term and long-term safety profile has not been established.

People should also avoid assuming that a compound is safe simply because it is described as a “research chemical.” Research status does not mean that a substance has received medical approval or passed the safety testing required for an approved medicine.

Is 4-MeTMP Approved as a Medicine?

4MeTMP should not be confused with prescription methylphenidate. It does not have the same established medical status or evidence base as approved methylphenidate medicines.

In addition, legal controls can differ between countries and can change over time. Therefore, anyone conducting legitimate research should check the current regulations that apply to the relevant jurisdiction before handling the compound.

4-MeTMP Research Summary

4MeTMP remains an interesting compound for chemical, pharmacological, ADME, and forensic research. Its relationship with methylphenidate makes it useful for studying how small structural changes can influence stimulant pharmacology.

At the same time, researchers should interpret available information carefully. Current studies include computational predictions and experimental pharmacology, but they do not establish 4-MeTMP as a safe or effective medicine. More controlled research is needed to understand its pharmacokinetics, toxicity, pharmacodynamics, and long-term effects.

Frequently Asked Questions About 4-MeTMP

What is 4MeTMP?

4-MeTMP is the abbreviation commonly used for threo-4-methylmethylphenidate, a synthetic stimulant related structurally to methylphenidate.

What is the molecular formula of 4MeTMP?

The molecular formula is C15H21NO2, with a molecular weight of approximately 247.33 g/mol.

Is 4MeTMP the same as methylphenidate?

No. Although the compounds have related structures, 4-MeTMP is a distinct chemical compound with its own pharmacological and toxicological profile.

Is 4MeTMP safe?

Its complete safety profile has not been established. Current research provides useful chemical and pharmacological information, but additional toxicological and clinical research is required.

Is 4-MeTMP used medically?

There is no established approved therapeutic use comparable to prescription methylphenidate. Current literature primarily discusses 4MeTMP in research and forensic contexts.

Conclusion

4MeTMP is a synthetic phenidate-related stimulant that continues to attract scientific and forensic interest. Its chemical structure, relationship to methylphenidate, and predicted ADME characteristics make it a subject of ongoing research. Nevertheless, limited human safety data means that researchers should treat available information cautiously. More laboratory and toxicological studies are necessary before scientists can fully understand its risks and pharmacological profile.